# TELA Bio, Inc.: Form SCHEDULE 13D, filed Jun 9, 2026

- Company: [TELA Bio, Inc.](/companies/tela.md) (CIK 1561921)
- Form: SCHEDULE 13D
- Filed: 2026-06-09
- Accepted by EDGAR: Jun 9, 2026, 18:29 ET
- Period: not reported
- Accession: 0001193125-26-264406
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1561921/000119312526264406/xslSCHEDULE_13D_X02/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1561921/000119312526264406/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1561921/000119312526264406/xslSCHEDULE_13D_X02/primary_doc.xml

Filed Jun 9, 2026.
Source: SEC EDGAR, the filing index for accession 0001193125-26-264406. Last ingested by Listed: Nov 14, 2026, 23:11 ET. No prices; not investment advice.
